AHPPI Annual Meeting 2022
Wednesday 07 December, 09.00 – 17.00
Royal College of Obstetrics and Gynaecologists
10-18 Union Street, London, SE1 1SZ
We are pleased to present the programme for this year’s AHPPI Annual Meeting.
Impending change, innovations and future challenges
|09:00||Arrival and Coffee|
|09:15||Welcome and opening remarks||Dr Tim Hardman, Chairman AHPPI|
|09.30||Morning Session||Chaired by Dr Jörg Taubel, Richmond Pharmacology|
|09.30||Challenges of bringing a gene therapy to the clinic||Dr Piv Sagoo, Orchard Therapeutics|
Oxford debate: The ethics requirements for conducting Phase I trials be the same in oncology patients as healthy subjects
|For the motion: Dr Stephanie Ellis, HRA
Against: Dr Ayad Abdul-Ahad, Niche Science and Technology
|10:50||Tea/Coffee & Networking|
|11:20||The role of the Qualified Person in post Brexit Britain?||Dr Pam Turner, PNR Pharma|
|11:50||Using remote sampling in clinical trials||Dr Neil Spooner, Spooner Bioanalytical Solutions|
|12:20||Lunch and networking|
|13:20||Afternoon Session||Chaired by Dr Jim Bush, Labcorp|
|13:20||Keynote speech: A retrospective of 30+ years in early clinical development||Dr Liz Allen, IQVIA and Dr Tim Mant, IQVIA|
|14:00||Conducting challenge trials in healthy volunteers and patients – lessons learned||Dr Stephanie Ellis, HRA|
|14:45||What is the cost of a day in clinical development?||Dr Graham Wylie, MRN|
|15:20||Tea/Coffee & Networking|
|15:50||The status of the investment markets and early Phase investment||TBC|
|16:30||Discussion session: Conducting interactions with the MHRA||Dr Keith Berelowitz, Richmond Pharmacology|
|17:00||The current state of Investigator training in the UK||Dr Ulrike Lorch, Richmond Pharmacology and Kirsty Wydenbach, Weatherden|
|17:30||Discussion and closing remarks||Dr Tim Hardman, Chairman, AHPPI|
|17:40||Reception||The meeting will be followed by networking with mulled wine, elderflower pressé and both mince & pecan pies.|
Members of AHPPI qualify for discounted rates – join here.
CPD points for this meeting have been applied for.
Please contact Tim Hardman with any questions.
We are extremely grateful to Richmond Pharmacology for their sponsorship of the meeting.